Regeneron Pharmaceuticals Inc (MEX:REGN)
MXN 18667 16.7 (0.09%) Market Cap: 2.04 Tn Enterprise Value: 1.90 Tn PE Ratio: 24.59 PB Ratio: 3.63 GF Score: 92/100

Regeneron Pharmaceuticals Inc at Jefferies London Healthcare Conference Transcript

Nov 16, 2022 / 03:15PM GMT
Release Date Price: MXN14167.14
Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

All right. Well, good afternoon. Day 2 of the London Healthcare Conference. My name is Akash Tewari. I'm one of the therapeutic analyst here. I hope you guys are all enjoying yourself. I'll tell you, it's wonderful to see everyone back, it really is. So today, I have the pleasure of hosting Regeneron. Joining us today, we have Robert Landry, CFO; and then Ryan Crowe, Head of IR. Before we get into some of the specific questions we had, maybe Robert and Ryan, do you want to open up with some introductory remarks, and we can take it from there.

Ryan Crowe
Regeneron Pharmaceuticals, Inc. - VP of IR

Sure. Absolutely.

Akash Tewari
Jefferies LLC, Research Division - Equity Analyst

Do you mind closing the door, please?

Ryan Crowe
Regeneron Pharmaceuticals, Inc. - VP of IR

Yes. I'll just start here with some -- and thank you for having us, Akash. Great to be in London meeting with everybody and certainly a very

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot